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Abstract
Aims: This review investigates the factors that influence deprescribing ofmedications
in primary care from the perspective of general practitioners (GPs) and community‐living
older adults.
Methods: A mixed studies review structure was adopted searching Scopus,
CINAHL, PsychINFO, ProQuest, and PubMed from January 2000 to December
2017. A manual search of reference lists was also conducted. Studies were included
if they were original research available in English and explored general deprescribing
rather than deprescribing of a specific class of medications. The Mixed Methods
Assessment Tool was used to assess the quality of studies, and content analysis
generated common categories across studies.
Results: Thirty‐eight articles were included, and 7 key categories were identified.
The review found that the factors that influence deprescribing are similar across and
within health systems and mostly act as barriers. These factors remained unchanged
across the review period. The structural organisation of health systems remains poorly
suited to facilitate deprescribing. Individual knowledge gaps of both GPs and older
adults influence practices and attitudes towards deprescribing, and significant commu-
nication gaps occur between GPs and specialists and between GPs and older adults. As
a result, deprescribing decision making is characterised by uncertainty, and depre-
scribing is often considered only when medication problems have already arisen. Trust
plays a complex role, acting as both a barrier and facilitator of deprescribing.
Conclusions: Deprescribing is influenced by many factors. Despite recent interest,
little change has occurred. Multilevel strategies aimed at reforming aspects of the
health system and managing uncertainty at the practice and individual level, notably
reducing knowledge limitations and closing communications gaps, may achieve change.
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1 | INTRODUCTION
Polypharmacy use in older adult populations is increasing.1,2 A number
of reasons have been suggested for this, including the use of disease
specific treatment guidelines in the context of multiple morbidities,
lower treatment thresholds for chronic diseases,3 the ongoing use of
preventives,4 and the medicalisation of some of the normal processes
of aging.5 The use of polypharmacy, commonly identified as taking five
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or more concurrent medications, may be appropriate in some circum-
stances.6 However, it also places older adults at a potentially higher risk
of adverse drug reactions,7 resulting in increased personal and health
care costs, hospitalisations, poor health outcomes,8 and/or increased
mortality rates.9 This level of risk is considerable10 and as such,
warrants further attention as a public health11 and ethical issue.12
Medications are rarely indicated for lifelong usage, as many fac-
tors may change during the course of treatment.13 This is due, in part,
to the complexity of managing multiple morbidities experienced by
many older adults, the lack of evidence available to inform decisions
and changes in health, frailty, and, often, autonomy.14 As a result,
older adults and their general practitioners (GPs) face particular chal-
lenges when deciding on the most appropriate treatment regimens.
Deprescribing has been suggested as one intervention to reduce
inappropriate polypharmacy.7 The term deprescribing was first used
by Woodward15 and is defined as a systematic process supervised
by a medical professional to reduce or discontinue long‐term medica-
tions.16 Deprescribing is indicated where the existing or potential
harms outweigh existing or potential benefits of a particular medica-
tion/medications. Deprescribing may be relevant at any point in the
life course, although it is most often considered in the context of med-
ication use for older adults who, as a group, are growing exponentially
worldwide.17 Ideally, the process of deprescribing takes into account
changes in the context of an individual's treatment goals, their current
level of functioning, life expectancy, values, and preferences.18 How-
ever, it is not a process that is routinely considered in primary care.7
This is despite evidence of the usefulness of deprescribing to address
polypharmacy and reduce mortality,19 and an increased awareness of
deprescribing at both international20 and at national levels.6,21,22
Three previous literature reviews in this research area are avail-
able.23-25 One examined the barriers and facilitators of deprescribing
from the perspective of patients, using a narrative synthesis of qualita-
tive, quantitative, and mixed methods studies.25 Anderson et al,23 on
the other hand, sought to understand barriers and facilitators from
the perspective of the prescriber, conducting a synthesis of qualitative
studies. These initial reviews by Reeve et al25 and Anderson et al23
were conducted just as interest in this research area gained momentum
with most papers being published26 since 2015. As such, they were
exploratory and broad in scope, being conducted across all health care
settings, targeting deprescribing in the context of all adult aged patient
groups, and included both general deprescribing and deprescribing of
single medication types. A further ethnographic review by Bokhof and
Junius‐Walker24 had a narrower focus, synthesising findings from qual-
itative research, to investigate the management of and attitudes
towards reducing polypharmacy (including deprescribing), from the per-
spective of both community‐living older adults and GPs. This is impor-
tant because, as mentioned earlier, deprescribing is most often
considered in the context of the treatment of older adults.
The purpose of the current review is to build on Bokhof and Junius‐
Walker24 work by investigating the factors that influence deprescribing
from the perspective of both GPs and adults aged 65 years or older.
Independent, community‐living older adults are the focus of this
review, as the majority of this group retain autonomy and are capable
of being responsible for their own health decisions,17 hence the impor-
tance of considering deprescribing from their perspective. Given the
increasing evidence that is now available on this topic, a review that
incorporates all study types is warranted. Interventions to promote
deprescribing will require change on the part of both prescribers and
older adults, so it is important to consider how their views interact to
create the context where deprescribing discussions can take place.
2 | METHODS
A mixed studies review methodology was used as a guide to explore
the factors that influence deprescribing.27,28
2.1 | Eligibility criteria
2.1.1 | Inclusion criteria
Full text primary research articles were included that were available in
English, published between January 2000 and December 2017, and
that investigated deprescribing or medication cessation/discontinua-
tion in the primary care context for older adults, living independently
in the community. General deprescribing was targeted. Articles were
also included where deprescribing was mentioned as a mechanism to
reduce polypharmacy or potentially inappropriate medications or in
the context of the management of multiple morbidities.
2.1.2 | Exclusion criteria
Deprescribing of specific medications or medication classes were not
included, as unique factors related to individual medication use, such
as specific withdrawal issues, might have influenced deprescribing
practices and attitudes in these instances. Articles discussing
deprescribing within long‐term residential aged care facilities were
excluded, as the nature of such care changes the relationship between
primary care providers and older adults, limiting the ability of older
adults to act autonomously.29 Similarly, articles discussing
deprescribing within acute care hospital settings were excluded, as it
is less likely that there is an established, ongoing relationship between
the prescriber and older adult in these settings. Articles were also
excluded if they only related to discontinuing medications during palli-
ative stages of care, as the context of medication deprescribing is mark-
edly different in these scenarios.30
2.2 | Literature search
An initial scoping search was conducted in August 2016; however,
due to the rapid proliferation of research in this area, a further search
of the following 5 databases was conducted in November 2017:
CINAHL, PsychINFO, ProQuest, PubMed, and Scopus. The results
are shown in Figure 1.
The search was conducted using combinations of the following
search terms and the Boolean operator “AND.”
• “older adult” OR senior* OR elder*
• “general practice” OR “general practitioner” OR GP OR “family
physician” OR physician OR “primary care” OR doctor OR clinician
OR prescriber OR “health professional” OR “health care
professional”
2 of 13 GILLESPIE ET AL.
• deprescribe* OR discontin* OR cessation OR cease OR
withdraw*OR stop* OR reduc* OR optim*
• polypharmacy OR medication OR medicines OR prescribing OR
“prescription drug”
An example search strategy is detailed in Appendix S1.
Search terms were applied to abstracts, keywords, and titles. In
addition, a secondary search of reference lists of relevant articles
was conducted, to check for other potentially eligible articles. The
search was conducted by the main author, following refinement of
the search terms under the guidance of a university librarian.
2.3 | Identifying and selecting relevant articles
After duplicate citations were removed, one reviewer (RG) screened
titles for relevant articles. Abstracts and/or full texts were reviewed if
the article met the inclusion criteria. Key data from potential articles
were extracted into a table. This was reviewed by all authors to confirm
the relevance and appropriateness of each article. As the focus of the
review was on autonomous community‐living adults, any articles that
included community‐living older adults with cognitive impairment were
excluded.
2.4 | Quality assessment of included articles
The quality of the included articles was assessed using the Mixed
Methods Appraisal Tool (MMAT).31 This checklist is suited for use
when studies with a range of methodological techniques need to be
assessed. The first 2 authors screened the studies to determine their
quality rating, applying the scoring system described in Pluye et al,32
and scores were confirmed by the third author.
2.5 | Analytic approach
The findings sections of included studies were analysed using content
analysis.33 Findings were explored across all articles to identify factors
influencing deprescribing. The first author became familiar with the
content by reading each study multiple times. Unique codes were
identified and tabled. The relationship between codes was considered
in order to organise the codes into groups. These groupings were
discussed by all researchers in order to refine the final categories.
Seven key categories were generated from the data.
3 | RESULTS
Searchesofelectronicdatabasesandthereference listsof relatedarticles
identified4604potentially relevant articles. Following the application of
the exclusion and inclusion criteria, 38 articles remained and were
reviewed (Figure 1). Table 1 summarises the data from the included
studies. The studies were conducted across a number of countries with
varied health systems. Only 2 studies included the perspectives of both
GPsandmedicationusers.61,68Thirteenstudies includedonlyolderadult
participants. The remainder includedGPs (family physicians) (n = 16) or a
FIGURE 1 PRISMA flow chart of study
inclusion
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mix of primary care prescribers including GPs, nurse practitioners, GPs'
assistants, consulting pharmacists, and geriatricians (n = 7).
The majority of the studies (n = 28) used qualitative methods,
eg, focus groups, semistructured interviews, and Delphi approach;
one used mixed methods,41 and 9 used quantitative
methods.44,48,51,52,57,58,65,68,69
3.1 | Quality of the included studies
The quality of the included studies varied (see Table 1). All but one
study44 reached 50% or more in the MMAT appraisal score. The 2
researchers who applied the MMAT came to a consensus, prior to
the use of the tool, on the meaning of the criteria applied to the
qualitative studies. This is recommended by the MMAT developers.31
This may mean that we applied the tool differently than others. Few
qualitative studies included researcher reflexivity as required by the
MMAT. Response rates for the quantitative surveys of GPs were
generally low, with no study reaching the required MMAT response
rate (≥60%). However, it should be noted that a low response rate
is typical when surveying this population72 and that the responses
were adequate to address the descriptive, exploratory aims of the
studies. The 2 studies that used a modified Delphi technique were
not scored, as the criteria used in the tool were found to be not
applicable.
3.2 | Findings
Seven key categories were identified that influence deprescribing.
These were the health care system, older adult and GP characteristics,
knowledge limitations, beliefs about medication use, GPs' perceptions
of older adults, older adults' perception of GPs, and fears regarding
deprescribing.
3.2.1 | The health care system
The structures and practices within the health care systems repre-
sented in the 38 included studies generated a variety of factors that
influenced both GP prescribers and older adults, and were noticeably
similar despite the variety of systems represented. These ranged from
macroorganisational factors such as how care is managed and distrib-
uted across multiple care providers, down to the management of indi-
vidual practices, for example, regarding time management and
delegation of tasks.
Older adults often need to consult with more than one
prescriber in the course of managing multiple morbidities; this may
result in an increased risk of poor communication regarding medica-
tions between prescribers and confusion about responsibili-
ties.34,35,38,40,46,50,56,61,62,66,67 General practitioners view this as a
potential barrier to enacting deprescribing. They felt that specialist
prescribers regarded their treatment as a priority62,64 and focused
on a specific area, resulting in no one taking responsibility over-
all.66,67 Also, patients sometimes believed that specialists had more
authority than GPs34,49,59 and faced confusion about which
prescriber was responsible for, and authorised to deprescribe.49
Conversely, GPs and older adults valued the long‐term relation-
ships that they developed in the primary care context, and this worked
to facilitate deprescribing. Familiarity allowed GPs to build trust and
gain an overview of their older patients' preferences, health concerns,
and medications.35,50,53,70 General practitioners generally felt that this
positioned them as the gatekeepers or coordinators of their older
patients' care.53,60,66,67 However, this perception was contradicted
by another recurrent dialogue where GPs noted that the hierarchy
between themselves and their specialist counterparts prevented them
from questioning medication prescribing decisions, even if it meant
continuing medications with no clear indications or that were poten-
tially inappropriate.35,38,40,46,50,54,56,62,63
Both older adults and their GPs thought that there was not
enough time during consultations to review medications, consider
patient preferences, and determine the priorities patients val-
ued.34,37-39,48,50,53,55,56,60,61,63,64,66,70 Furthermore, GPs were not ade-
quately reimbursed for more complex consultations, especially with
patients with multiple morbidities,53,67 including undertaking medica-
tion reviews, and deprescribing discussions and follow‐up.34,35,46,56
Some GPs avoided addressing complex issues because of their aware-
ness of the lack of time.60,66
Access to support alongside or within individual practice organisa-
tions may influence deprescribing. Changes in practice were suggested,
including the ability to consult with pharmacists,50,51,60,62,63 inviting fel-
low GPs to conduct independent prescribing reviews,38 phone consults
with geriatricians and/or specialists,66 and referrals to services able to
provide nonpharmacological options.70 However, it is notable that the
GPs in the study by Sinnige et al63 only sought help when their patient's
condition did not improve. The use of information technology applica-
tions designed to monitor and support prescribing was met with some
caution. These were regarded as not well suited to prescribing in the
context of the complex needs of the individual older patient with mul-
tiple morbidities.50,60,63
Delegation of tasks to other team members was mentioned,51,70
such as medication reconciliation to nurses50 or follow‐up to pharma-
cists.57,58 In practice, this may not happen, as some GPs were uncom-
fortable with delegation, fearing it would undermine their
accountability and authority as a prescriber.50
Disease‐specific treatment guideline use generated much concern
among GPs, who thought that they promoted ongoing prescribing and
encouraged polypharmacy.35,37,56,62,66,70 General practitioners noted
that guidelines did not take into account treatment decisions in the
context of multiple morbidities or provide guidance on the appropriate
circumstances in which to discontinue medications.37,46,47,53,56,62,64,67
Additionally, GPs felt unsure of the usefulness of guidelines, because
they were based on clinical trials that rarely included older adults,
especially those with multiple morbidities,37,46,56 and did not take into
account outcomes valued by the patient.46
The way guidelines were used varied among GPs, with those in the
study of Sinnott et al64 prioritising themanagement of one disease over
another, whereas those in another study62 seemed to apply guidelines
one after another, without ranking which treatment wasmost essential.
Some GPs were less concerned about following guidelines when pre-
scribing for older patients, preferring to prioritise quality of life,53,63
while others thought that the use of guidelines would ensure best prac-
tice.46 General practitioners were hoping for more useful tools to help
them rank the treatment of various diseases,67 recognise potentially
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inappropriate medications,39 or guide deprescribing of specific classes
of medication.44
3.2.2 | Older adult and GP characteristics
General practitioners' approaches to the management of their older
adults' medications varied.46,50,63 A range of characteristics influenced
this. General practitioners who had more years of clinical experience
were less likely to be concerned about adhering to clinical guidelines,
and based their decisions on their clinical reasoning skills and being
mindful of the individual needs of their older patients' overall treat-
ment and preferences.34,56,62,64 General practitioners who had
deprescribed medications successfully in the past were more likely
to do so in the future.34,50
General practitioners ranked factors that might motivate them to
deprescribe, from most to least important and used this as a guide.
These factors included cognitive impairment, limited life expectancy,
wishes of patient or family, number of medications, and the level of
functional dependence.48 These changing clinical characteristics
encouraged GPs to consider deprescribing because they perceived that
the risk of medication continuation exceeded the risk of
deprescribing.48,50 In this context, some GPs felt more comfortable
introducing the topic of deprescribing during discussions with patients
about their quality of life versus life expectancy,62 although others
remained uncomfortable believing their patients would think they had
been given up on.48,62,64,70
Concerns about polypharmacy use in their older adult patients
were frequently raised by health care providers.34,35,40,50,53,56,62,66,67
However, their views of what constituted polypharmacy varied,50,56
and this was often assessed in an individual, case‐by‐case
manner.34,50,56 Increased pill burden or the number of medications
was a factor in triggering a medication review with a view to
deprescribing.48 Some prescribers in another study thought that
polypharmacy should be framed as a risk to patients who are aging
in the same way as they would frame a discussion about the risk of
other health problems such as stroke.34
Older adults varied in their interest for more information about
their medications and involvement in decision making.61,71 For exam-
ple, raising the topic of discontinuing a medication was initiated by only
18% of older adults in a Norwegian study,68 while 55% had done so in a
US study51 and 42% in a Canadian study.69 The Canadian study found
that initiating a deprescribing conversation was more likely in older
adults who searched for information about and had an awareness of
medication harms.69 In contrast, some older adults felt fearful about
expressing their medication preferences and did not share their experi-
ence of trialling deprescribing themselves until after the fact.42,61,71
3.2.3 | Knowledge limitations
Knowledge limitations were commonly cited as a major barrier. Gen-
eral practitioners reported that knowledge gaps, particularly in their
pharmacological knowledge, negatively impacted their confidence
and willingness to deprescribe.34,35,50,60,62,66 They were unsure of
the potential interactions between multiple medications,35,56,62 unsure
of the ongoing benefit of long‐term medication use (eg, preven-
tives),43,56,62 and unsure of the outcome of deprescribing.34,37 In
practice, then, GPs make assessments of the potential harms or bene-
fits of medication based on the individual needs of their patients.53,54
Additionally, GPs lacked information about nonpharmacological
options39 and how to develop, implement, and monitor a
deprescribing plan.44 Furthermore, GPs in the study by Riordan
et al60 noted that they were still influenced by pharmaceutical com-
pany salespeople, even though they perceive their information to be
biased.
An incomplete clinical picture regarding their older patients was
another knowledge limitation that negatively impacted GPs' capability
to deprescribe. This may result from patients not communicating
important information regarding their medications.35,37,50,56,61 Further-
more, other prescribers, such as medical specialists, may not effectively
communicate all their treatment plans (eg, medication indications and/
or duration of treatment) to the GP.34,35,38,40,46,48,50,51,70
Older adults had limited knowledge about their medications. The
study by Weir et al71 found that this affected their confidence to ini-
tiate deprescribing discussions. The reasons for and the potential
harms of their medications were not always known,71 or the ongoing
need for some medications was not clear.55 Patients assumed, as their
doctor had more medical knowledge than they did, that it must be
appropriate to continue their medication, otherwise, their doctor
would stop writing repeat prescriptions.59 Poor health literacy may
also be a factor that influences deprescribing decision making.41 Gen-
eral practitioners in Clyne et al39 earlier study thought that they may
be able to negotiate with patients to motivate them to consider
deprescribing if they could give their patients more information about
their medications.
Previous experiences of deprescribing varied, with 34% in a US
study,51 40% in a Canadian study,65 and 55% in an Australian study58
having experienced deprescribing. Knowledge of the process of
deprescribing was limited, for example, with regard to tapering dos-
ages or trialling deprescribing59,68 or with regard to the potential
reduction in risks that deprescribing offers.45
3.2.4 | Beliefs about medication use
General practitioners generally held positive beliefs about medications.
Their previous experiences of the clinical usefulness of medications and
their belief that they generally cause few serious side effects resulted in
them favouring continued prescribing over deprescribing.37,43 This bias
towards prescribing was further promoted by the uncertain outcome of
deprescribing.34,70
In comparison, older adults hold conflicting ideas around medica-
tion use, often expressing concurrent positive and negative
beliefs.36,41 These conflicting beliefs are clearly illustrated in the 3
quantitative studies that used the Patient's Attitudes Toward
Deprescribing survey. Reeve et al,58 Sirois et al,65 and Ng et al57 found
that while a majority of older adults thought that all their medications
were necessary (95%, 84%, 89%, respectively), similar numbers indi-
cated a willingness to consider deprescribing, if their doctor thought
it were possible (92%, 71%, 93%, respectively).
Older adult responses in many of the qualitative studies elaborate
on the reasons for their conflicting beliefs. Medications were valued,
as they were perceived to extend life and improve well‐being, and
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their use was to be expected during older age.71 Older adults were
more likely to believe that their medications were necessary following
the testimony of their GP,59 recall of the usefulness of medications for
family members and friends,71 ongoing symptom relief,36,41,71 or
avoidance of preventable health issues.55 Concurrently, older adults
expressed a strong dislike of using medications long‐term. They prefer
to take as few as possible.42,49,55,68,71 Sometimes, nonpharmacological
options were followed in order to stop medications.42 From a practical
point of view, taking multiple medications was perceived to be a bur-
den by some,36,71 and notably, in the US health system, was costly.42
When taking into account competing outcomes, older adults valued
ongoing quality of life more than extending life expectancy, suggesting
that, if the side effects from a particular medication were too signifi-
cant, they may consider discontinuing that medication.45,59
3.2.5 | GP perceptions of older adults
General practitioner perceptions of their older patients influenced
their willingness to consider raising the topic of deprescribing. General
practitioners perceived their older patients to be generally resistant to
change and that they would be unlikely to accept their advice to
deprescribe,35,37,43,50,62 especially if they suggested stopping a medi-
cation which the older adult perceived was giving them symptom
relief.37 Alongside this, some believed that older adults themselves
had no problem with polypharmacy.62 Explanation of potential risks
and uncertainties was seen as being particularly hard.47,64 General
practitioners in the study by Schuling et al62 noted that explaining
deprescribing to their older patients was made more difficult because
of their patients' age and sometimes their poor education. Another
study, however, also of Dutch GPs, noted that some believed that
even very old people were capable of entering into a shared
decision‐making process.53
General practitioners felt pressured to meet their older adults'
(and/or family members') expectations to prescribe medications,37-
39,54,56,60,70 although some noted that with careful explanation, they
may accept the suggestion of alternative treatments.37-39 General
practitioners in the study by Wallis et al70 observed that it is important
to remember that patients are not coming to an appointment
expecting a discussion about deprescribing.
3.2.6 | Older adults' perceptions of their GP
Trust was an important factor mentioned in multiple studies. Older
adults' hypothetical interest in deprescribing was associated with a
higher physician trust score.57,58 However, in practice, those who
reported higher trust were less likely to have experienced
deprescribing.52 Older adults reported that their trust in the prescrib-
ing practices of their GP was based on the perceived clinical knowl-
edge of their GP, a belief that their GP would make decisions with
their best interests in mind, and on the strength of the relationship
established between themselves and their GP based on mutual
respect, good communication, and knowledge of their prefer-
ences.36,41,49,55,59,61,68,71 Sometimes, this level of trust meant that
they did not ask for important medication information.61 Some older
adults did qualify their trust, suggesting that they needed to find infor-
mation for themselves in order to maintain responsibility for their own
health.55,49,71 Others remarked on the paternalistic nature of their
relationship with their GP, although they were generally accepting of
this, that it was wise not to argue, and preferred to follow their
doctor's advice.41,61,71 Weir et al71 compared attitudes of older adults
across 3 groups and noted that those who were frailer and/or lacked
an understanding of their medications were happy to abdicate deci-
sion making about their medications, including deprescribing, to their
doctor.
Both GPs and older adults recognised that trust could be
undermined when different prescribers gave conflicting advice about
deprescribing.38,49,55,62,68 Finally, others, in the study by Moen
et al,55 noted a general distrust of the health system rather than of a
specific prescriber and were sceptical about the ongoing influence of
pharmaceutical companies on prescribers.
3.2.7 | Fears
Both older adults and GPs feared the potential for unfavourable out-
comes from deprescribing, such as a return of symptoms, withdrawal
effects, or previously avoided serious events such as stroke, occur-
ring following the cessation of preventative medica-
tions.34,37,42,50,61,62,68,70,71 This fear often outweighed the fear of
risks associated with continuing multiple, sometimes potentially inap-
propriate, medications from the perspective of both patients71 and
prescribers.37,64 As a result, maintaining the status quo was pre-
ferred. However, older adults' fears of, or experience with, side
effects,42,55,68 drug interactions when using multiple medications,
and/or fear of addiction,55 were factors that could influence them
to consider the acceptability of deprescribing.
General practitioners feared that a poor outcome as a result of
their deprescribing advice would undermine their relationship with
their patient or family members62,64,70 and could lead to litiga-
tion.61,62,64 Others sought to shift the responsibility for a recommen-
dation to deprescribe, by referring to the requirements of external
parties such as drivers' licensing bodies.37
4 | DISCUSSION
As far as we are aware, this is the first mixed studies review to consider
the factors that influence deprescribing for both community‐living older
adults and GPs. Compared to earlier reviews, the inclusion of recent
quantitative papers allowed us to note the strong interest of older
adults in deprescribing if recommended to do so by their doctor. This
suggests that GPs' fear of patient resistance may often be unfounded.
Additionally, we noted the priority GPs give to various patient related
factors when considering deprescribing, including cognitive impair-
ment, limited life expectancy, and patient or family preferences. Know-
ing the original medication indication, having assistance to monitor
deprescribing, and further involvement of patients in shared decision
making were ranked as being the most helpful for prescribers to enable
deprescribing.
Additionally, we found that the factors that influence
deprescribing have remained unchanged over the time period covered
by the review and are similar across all of the health systems repre-
sented. This is important to note, as there has been an increase in
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research in this area in the last decade and this appears to have had
little impact on primary care practice. In their systematic review of
the knowledge to practice gap, Lau et al73 argue the importance of
moving beyond the identification of barriers and facilitators, if change
is to be achieved. Most studies continue to identify barriers and
facilitators to deprescribing and examine these as separate factors,
without considering the relative importance of each of them or how
they interact.
This review of the current literature suggests that the factors that
influence deprescribing mostly act as barriers. Some are created by the
health system, which provides the context for deprescribing, while
other barriers occur at the practice and individual level. At the individ-
ual level, Bokhof and Junius‐Walker's24 review found that both older
adults and GPs faced uncertainty in deprescribing decision making,
and this finding is confirmed by this review. Individual level barriers
to deprescribing may be grouped into 2 key areas: knowledge limita-
tions and communication gaps. Reducing uncertainty in these 2 areas,
together with addressing health system constraints, could lead to
change in deprescribing practice.
4.1.1. | Health system constraints
Health system constraints, which can only be addressed at the policy
level, provide the context for any change at the practice level. Primary
care consultations continue to be best suited to managing acute health
problemsrather thanchronichealthconditionsormultiplemorbidities.74
Consultation times remain short, and reimbursement for more complex
tasks is still inadequate. These practical issues may mean GPs avoid
time‐consuming areas such as discussions about deprescribing, as they
seek to meet the needs of all their patients. As a result, deprescribing
tends to occur reactively when a significant medication related problem
arises orwhen there are other clear indications such as increasing cogni-
tive impairment or limited life expectancy. However, discussing
deprescribing earlier as a routine part ofmedicationmanagementwould
provide GPs with the opportunity to work collaboratively with the
patient, and othermembers of the health care team, to ensure thatmed-
ication regimens remain beneficial and manageable for the patient. Sev-
eral different models of integrated care, which focus on the
establishmentofmultidisciplinary teamsorprovidernetworkswithinpri-
mary care settings, have been shown to be successful in improving care
for those with chronic diseases.74 Such models could also facilitate
deprescribing and should be further researched.
4.1.2. | Knowledge limitations
General practitioners noted that they lacked pharmacological knowl-
edge in the context of treating older, multimorbid adults. This suggests
that medical curricula should be revised to include more specific geriat-
ric pharmacology and deprescribing education,75 together with ongoing
professional development after graduation. Pharmacists, located either
in the community or within GP practices, can also supply information.
Those located within GP practices may be better placed to collaborate
and meet the immediate information needs of GPs.76
The review found that the evidence available to guide GPs when
making prescribing decisions is limited. Clinical trials rarely include older
adults withmultiplemorbidities, and as a result, GPs have little evidence
of the effect of medications in real‐life patients.77 Furthermore, this
group is excluded from most randomised control trials for the develop-
ment of evidence‐based medicine and clinical practice guidelines.78
Experienced GPs manage this lack of evidence by drawing on their own
clinical knowledge base, deviating from clinical guidelines as required,
and taking into account quality of life considerations and patient prefer-
ences. This suggests that those who are less experienced may benefit
from more structured opportunities to draw on the knowledge base of
others such as pharmacists, geriatricians, and peers, to review
deprescribing decisions in the context of complex medication regimens.
Paternalistic relationships and the asymmetry of medical knowl-
edge undermine some older adults' confidence to discuss their prefer-
ences with their GPs and/or ask questions to clarify information gaps.
This finding is similar to an earlier review on communication about
medicines between patients and health care professionals.79 To
ensure that older adults have an opportunity to make informed deci-
sions, changes in medication information for patients are required to
ensure that this is accessible and understandable, irrespective of the
health literacy level of the individual. This should include information
regarding how medications are deprescribed. The lack of awareness
of monitored deprescribing as an option is demonstrated by those
older adults who discontinued medications themselves, without
discussing their decision with their GP.
4.1.3. | Communication gaps
The primary care model allows both the patient and their GP to
develop a relationship over time and was favoured by both parties in
the included studies. This was seen as especially important in the con-
text of managing chronic multiple morbidities. Awareness of patient
preferences and open, shared communication in the context of trust
reduces uncertainty. The earlier reviews by Reeve et al25and Bokhof
and Junius‐Walker24 identified trust as being an important character-
istic that was necessary to facilitate deprescribing, but the role of trust
may be more complex than this suggests. In some studies, trust is
associated with a willingness to consider deprescribing, suggesting
that it may facilitate acceptance of a prescriber's recommendation to
deprescribe, even in the face of uncertainty.57,58 However, other
research demonstrates that trust can also act as a barrier to
deprescribing. For example, trust was used by patients to explain
why they unquestioningly accepted their medication regimen,
resulting in lower reports of deprescribing.52 These contradictory
actions of trust were also demonstrated in the small study by Schöpf
et al61 included in this review and are similar to the findings regarding
trust in the study by Belcher et al80 of older adults' participation in
medication related decision making.
Because older adults often have more than one prescriber
involved in their care, good communication structures and practices
within and between health care providers are especially important.
Currently, GPs may receive little information about specialist consulta-
tion outcome/s. Furthermore, GPs sometimes continued medications
they considered inappropriate because they were not willing to chal-
lenge their specialist counterparts, and some older adults believed that
only their specialists had the authority to deprescribe. Despite these
challenges, GPs remain well placed to act as the overall coordinators
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of their older adults' medication regimens as they may be the only pre-
scriber who can see the full picture of what is being taken. This sug-
gests that a collaborative approach with improved communication
between specialist and GP prescribers is needed, along with clarifica-
tion of lines of responsibility.
4.2 | Areas for further investigation
Future deprescribing research needs to explore aspects of diversity
among older adults. Age was used to define the samples in the
reviewed studies; however, chronological age is only loosely related
to physiological changes that occur during the aging process, suggest-
ing that this group should not be thought of as homogenous. The
majority of older adults continue to live in the community and are a
diverse group that contribute to society as mentors, consumers, mem-
bers of the workforce, caregivers, and innovators, despite the chal-
lenges of the aging process.17
The review highlights that several other areas also require further
exploration. Work is required to understand the extent to which
health literacy, which is known to be lower in this age group,81 and
socio‐economic characteristics influence older adults' decisions. Addi-
tionally, research is required to further understand the complex role
of trust within long‐term doctor‐patient relationships, as it applies
to deprescribing.
4.3 | Limitations
Our review only included studies available in English. Despite the
search methodology including multiple databases and a variety of rel-
evant search terms, a significant number of the included studies were
identified via hand searches of reference lists of related articles and
using citation tracking. This reduces the reproducibility of our
methods. Finally, the MMAT used to assess the quality of the included
studies is still in development, so the quality scores given should be
treated cautiously.
5 | CONCLUSION
This review investigated the factors that influence deprescribing from
the perspective of both GPs and older adults aged 65 years or older
and living independently in the community. The review found that
these factors mostly act as barriers to prevent deprescribing from
entering into discussions during consultations. They have remained
static across the review period and are similar across health systems.
To achieve change, multilevel strategies should be prioritised to
address structural constraints within health systems and to manage
uncertainty at the practice and individual level, reducing knowledge
limitations and closing communication gaps.
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